Table 2.

Rhythm and Rate Control Medication Use at Baseline and at Any Time During Follow-up

	Women, %		Men, %		P Value
Medication	Baseline	Follow-up	Baseline	Follow-up	Baseline	Follow-up
Amiodarone	5.1	19.5	6.5	26.2	.37	.02
Sotalol	5.6	14.4	6.0	14.8	.81	.86
Class 1 antiarrhythmics	8.0	26.2	6.7	22.5	.46	.19
β-Blockers	41.3	46.4	39.5	46.5	.57	.98
Calcium channel blockers	38.7	43.3	29.5	33.3	.003	.002
Digoxin	40.3	46.2	36.0	39.3	.18	.03